Germany
Japan
United Kingdom
China
Research Areas
Rabbit monoclonal anti-PD-L1 Antibody, clone OR-5H8
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
Rabbit monoclonal anti-PD-L1 Antibody, clone OR-5E3
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
Rabbit monoclonal anti-PD-L1 Antibody, clone OR-5E4
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
NFATC3 (Myc-DDK-tagged)-Human nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 (NFATC3), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
WNT7A (Myc-DDK-tagged)-Human wingless-type MMTV integration site family, member 7A (WNT7A)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL1A (Myc-DDK-tagged)-Human interleukin 1, alpha (IL1A)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
TCF21 (Myc-DDK-tagged)-Human transcription factor 21 (TCF21), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
WNT4 (Myc-DDK-tagged)-Human wingless-type MMTV integration site family, member 4 (WNT4)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
HLA (Myc-DDK-tagged)-Human major histocompatibility complex, class II, DR beta 1 (HLA-DRB1)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
FZD7 (Myc-DDK-tagged)-Human frizzled family receptor 7 (FZD7)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
WISP2 (Myc-DDK-tagged)-Human WNT1 inducible signaling pathway protein 2 (WISP2)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CSRP1 (Myc-DDK-tagged)-Human cysteine and glycine-rich protein 1 (CSRP1), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
ELK1 (Myc-DDK-tagged)-Human ELK1, member of ETS oncogene family (ELK1), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
PAK4 (Myc-DDK-tagged)-Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
SFRP5 (Myc-DDK-tagged)-Human secreted frizzled-related protein 5 (SFRP5)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
HLA (Myc-DDK-tagged)-Human major histocompatibility complex, class II, DR alpha (HLA-DRA)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Purified recombinant protein of Human receptor (TNFRSF)-interacting serine-threonine kinase 1 (RIPK1), full length, with N-terminal HIS tag, expressed in E.Coli, 50ug
| Tag | N-His |
| Expression Host | E. coli |
MAP3K7 (Myc-DDK-tagged)-Human mitogen-activated protein kinase kinase kinase 7 (MAP3K7), transcript variant A
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
FRZB (Myc-DDK-tagged)-Human frizzled-related protein (FRZB)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
WNT7B (Myc-DDK-tagged)-Human wingless-type MMTV integration site family, member 7B (WNT7B)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
WNT5A (untagged)-Human wingless-type MMTV integration site family, member 5A (WNT5A)
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
TOLLIP (Myc-DDK-tagged)-Human toll interacting protein (TOLLIP)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
ARAF (Myc-DDK-tagged)-Human v-raf murine sarcoma 3611 viral oncogene homolog (ARAF)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
RFX3 (Myc-DDK-tagged)-Human regulatory factor X, 3 (influences HLA class II expression) (RFX3), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CRK (Myc-DDK-tagged)-Human v-crk sarcoma virus CT10 oncogene homolog (avian) (CRK), transcript variant II
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
PRKCZ (Myc-DDK-tagged)-Human protein kinase C, zeta (PRKCZ), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
AGBL2 (Myc-DDK-tagged)-Human ATP/GTP binding protein-like 2 (AGBL2)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Lenti ORF particles, TMPRSS2 (Myc-DDK tagged) - Human transmembrane protease, serine 2 (TMPRSS2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Buy this product and get 50% off on the Lenti RapidTiter kit. Use Code: Rapid50
ROCK2 (Myc-DDK-tagged)-Human Rho-associated, coiled-coil containing protein kinase 2 (ROCK2)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
PTK2 (Myc-DDK-tagged)-Human PTK2 protein tyrosine kinase 2 (PTK2), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Wnt3a (Myc-DDK-tagged) - Mouse wingless-related MMTV integration site 3A (Wnt3a)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
MAP3K11 (Myc-DDK-tagged)-Human mitogen-activated protein kinase kinase kinase 11 (MAP3K11)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
IL1R1 (Myc-DDK-tagged)-Human interleukin 1 receptor, type I (IL1R1)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
GNAO1 (Myc-DDK-tagged)-Human guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O (GNAO1), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
LEF1 (Myc-DDK-tagged)-Human lymphoid enhancer-binding factor 1 (LEF1), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
DAXX (Myc-DDK-tagged)-Human death-domain associated protein (DAXX), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Recombinant protein of human v-raf murine sarcoma 3611 viral oncogene homolog (ARAF)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Il18 (Myc-DDK-tagged) - Mouse interleukin 18 (Il18)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
TRADD (Myc-DDK-tagged)-Human TNFRSF1A-associated via death domain (TRADD)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
FZD9 (Myc-DDK-tagged)-Human frizzled family receptor 9 (FZD9)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
WISP1 (Myc-DDK-tagged)-Human WNT1 inducible signaling pathway protein 1 (WISP1), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CD74 (Myc-DDK-tagged)-Human CD74 molecule, major histocompatibility complex, class II invariant chain (CD74), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
RYK (Myc-DDK-tagged)-Human RYK receptor-like tyrosine kinase (RYK), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
GSK3B (Myc-DDK-tagged)-Human glycogen synthase kinase 3 beta (GSK3B), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Lenti ORF particles, FURIN (Myc-DDK tagged) - Human furin (paired basic amino acid cleaving enzyme) (FURIN), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Buy this product and get 50% off on the Lenti RapidTiter kit. Use Code: Rapid50
IL1RAP (Myc-DDK-tagged)-Human interleukin 1 receptor accessory protein (IL1RAP), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
CCNL2 (Myc-DDK-tagged)-Human cyclin L2 (CCNL2), transcript variant 1
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Filter by
Target Symbol
- IL6 (279)
- TCF7L2 (219)
- ANAPC11 (217)
- MAPK8 (176)
- MAPK9 (170)
- IL1RN (159)
- TCF4 (140)
- CD4 (130)
- IL1RL1 (128)
- RORA (128)
- PECAM1 (121)
- PTK7 (119)
- LEF1 (112)
- ANAPC15 (109)
- MAPK10 (108)
- ROR2 (106)
- WNT3 (102)
- PTPRC (99)
- ESR1 (95)
- ANAPC10 (91)
- RYK (91)
- CD19 (90)
- KIT (89)
- ANAPC5 (88)
- ROR1 (88)
- CD99 (87)
- PDCD1 (87)
- IL6ST (85)
- ANAPC2 (84)
- FZD6 (83)
- DVL2 (82)
- LGALS3 (82)
- WNT5B (80)
- CEBPB (78)
- CD68 (74)
- WNT5A (71)
- CD34 (70)
- MS4A1 (70)
- TCF21 (70)
- CD5 (69)
- WNT2B (68)
- WNT16 (67)
- WNT7B (67)
- ENTPD6 (66)
- ROCK2 (66)
- NCAM1 (65)
- IL6R (63)
- TCF25 (63)
- WNT1 (63)
- ANAPC13 (62)
- IL1R1 (61)
- TNF (61)
- WNT9A (61)
- WNT3A (60)
- FZD4 (57)
- IL18R1 (57)
- TNFRSF8 (57)
- WNT10A (57)
- FZD3 (56)
- LRP5 (56)
- ROCK1 (56)
- WNT6 (56)
- FZD9 (55)
- LRP6 (55)
- WNT11 (55)
- ANAPC16 (54)
- CEBPD (54)
- IL36RN (54)
- FZD1 (53)
- FZD2 (53)
- ESR2 (52)
- FZD5 (52)
- WNT4 (52)
- HFE (50)
- CR2 (49)
- DVL3 (49)
- SLC25A23 (49)
- CD274 (48)
- CRP (47)
- MME (47)
- APOC2 (46)
- CASP1 (46)
- FRZB (46)
- WNT2 (46)
- WNT7A (45)
- FZD10 (44)
- JKAMP (42)
- CD2 (41)
- CD8A (41)
- DVL1 (41)
- LRP5L (41)
- AGTPBP1 (40)
- FZD7 (40)
- IL1RAP (40)
- CD22 (39)
- FCER2 (38)
- IL2RA (38)
- TYRO3 (37)
- CD14 (36)
- FZD8 (36)
Species
Reactivities
- Human (3258)
- Mouse (1128)
- Rat (880)
- Monkey (108)
- Dog (92)
- Bovine (27)
- Rabbit (17)
- Canine (16)
- Chicken (13)
- Hamster (12)
- Porcine (12)
- Gorilla (10)
- Bat (9)
- Horse (9)
- Gibbon (8)
- Pig (8)
- Canis (5)
- Chimpanzee (5)
- Primate (5)
- Cow (3)
- Xenopus (3)
- Guinea Pig (2)
- C. elegans (1)
- Equine (1)
- Frog (1)
- Macaque (1)
- Opossum (1)
- Orang-Utan (1)
- Rhesus Monkey (1)
- Sheep (1)
- Squirrel (1)
- Tobacco hornworm (1)
Applications
Antibody Hosts
Isotypes
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Expression Hosts
Lentivirus
Tags
- Myc-DDK (1612)
- Tag Free (838)
- mGFP (760)
- TurboGFP (575)
- C-MYC/DDK (531)
- C-Myc/DDK (296)
- tag free (43)
- His-tag (27)
- C-His (20)
- N-His (19)
- DDK-His (8)
- C-DDK/His (7)
- N-GST and C-HIS (6)
- N-GST and C-His (6)
- C-DDK (3)
- N-6His (2)
- N-Avi (2)
- T7-tag (2)
- C-Fc (1)
- C-HIS (1)
- C-Mouse Fc and 6×His (1)
- N-His-ABP (1)
Vectors
- pCMV6-Entry (1327)
- pCMV6-AC-GFP (575)
- pLenti-C-mGFP-P2A-Puro (563)
- pLenti-C-Myc-DDK-P2A-Puro (547)
- pGFP-C-shLenti (378)
- pLenti-C-mGFP (197)
- pRS (189)
- pLenti-C-Myc-DDK (168)
- EF1a-GFP-P2A-Puro (132)
- pCMV6-XL5 (121)
- pCMV6-XL4 (59)
- PCMV6-Kan/Neo (48)
- pGFP-V-RS (35)
- pCMV6-AC (34)
- pRFP-C-RS (14)
- GFP-puro (13)
- Luciferase-Puro (13)
- RFP-BSD (13)
- mBFP-Neo (13)
- pCMV6-XL6 (9)
- pCMV6-XL5-DDK-His (8)
- PCMV6-Neo (2)
Reporters
Modifications
- Unmodified (86)
- Phospho-specific (30)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (14)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (11)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (6)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- Phospho S1490 (1)
- Phospho T183/Y185 (1)
- Phospho T183/Y185,Phospho T221/Y223 (1)
- Phospho T235 (1)
- Phospho Y719 (1)
- This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
Protein Source
Assay Types
Assay Platforms
QC Levels
Mammalian Cell Selection
Families
- Druggable Genome (4905)
- Transmembrane (3057)
- ES Cell Differentiation/IPS (1561)
- Secreted Protein (1517)
- Protein Kinase (775)
- Transcription Factors (674)
- Adult stem cells (587)
- Embryonic stem cells (219)
- Cancer stem cells (209)
- Nuclear Hormone Receptor (199)
- Stem cell relevant signaling - Wnt Signaling pathway (193)
- GPCR (188)
- Induced pluripotent stem cells (150)
- Protease (141)
- Stem cell - Pluripotency (141)
- Phosphatase (96)
- Stem cell relevant signaling - DSL/Notch pathway (41)
- Stem cell relevant signaling - JAK/STAT signaling pathway (3)
Pathways
- Pathways in cancer (1531)
- Wnt signaling pathway (1372)
- Hematopoietic cell lineage (1281)
- Melanogenesis (1015)
- Basal cell carcinoma (936)
- Cell adhesion molecules (CAMs) (920)
- Colorectal cancer (833)
- Cytokine-cytokine receptor interaction (666)
- Progesterone-mediated oocyte maturation (660)
- Toll-like receptor signaling pathway (659)
- NOD-like receptor signaling pathway (579)
- T cell receptor signaling pathway (539)
- MAPK signaling pathway (494)
- Hedgehog signaling pathway (436)
- Focal adhesion (406)
- Graft-versus-host disease (398)
- Primary immunodeficiency (364)
- RIG-I-like receptor signaling pathway (364)
- Jak-STAT signaling pathway (363)
- Fc epsilon RI signaling pathway (361)
- Adipocytokine signaling pathway (351)
- Oocyte meiosis (347)
- Cell cycle (346)
- Type II diabetes mellitus (345)
- Neurotrophin signaling pathway (344)
- Ubiquitin mediated proteolysis (343)
- ErbB signaling pathway (341)
- Insulin signaling pathway (328)
- Antigen processing and presentation (325)
- GnRH signaling pathway (323)
- Epithelial cell signaling in Helicobacter pylori infection (321)
- Pancreatic cancer (320)
- Acute myeloid leukemia (299)
- Prion diseases (265)
- Leukocyte transendothelial migration (263)
- Cytosolic DNA-sensing pathway (252)
- Type I diabetes mellitus (241)
- Hypertrophic cardiomyopathy (HCM) (227)
- B cell receptor signaling pathway (223)
- Endometrial cancer (223)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (220)
- Adherens junction (215)
- Allograft rejection (214)
- Prostate cancer (214)
- Thyroid cancer (202)
- Endocytosis (171)
- Autoimmune thyroid disease (168)
- Systemic lupus erythematosus (159)
- Apoptosis (154)
- Viral myocarditis (153)
- Regulation of actin cytoskeleton (147)
- Asthma (141)
- Fc gamma R-mediated phagocytosis (130)
- Natural killer cell mediated cytotoxicity (107)
- Pathogenic Escherichia coli infection (102)
- Alzheimer's disease (98)
- TGF-beta signaling pathway (90)
- Chemokine signaling pathway (87)
- Notch signaling pathway (83)
- Amyotrophic lateral sclerosis (ALS) (79)
- Renin-angiotensin system (72)
- Lysosome (70)
- Axon guidance (64)
- Vascular smooth muscle contraction (63)
- Dilated cardiomyopathy (59)
- Complement and coagulation cascades (52)
- Metabolic pathways (31)
- Renal cell carcinoma (27)
- Chronic myeloid leukemia (23)
- Purine metabolism (23)
- Pyrimidine metabolism (23)
- Glutathione metabolism (21)
- ECM-receptor interaction (20)
- Glioma (19)
- VEGF signaling pathway (19)
- Long-term depression (18)
- PPAR signaling pathway (17)
- Non-small cell lung cancer (16)
- Bladder cancer (15)
- Tight junction (14)
- Long-term potentiation (13)
- Melanoma (13)
- Small cell lung cancer (12)
- mTOR signaling pathway (12)
- Gap junction (10)
- Huntington's disease (8)
- Circadian rhythm - mammal (5)
- Parkinson's disease (5)
- RNA degradation (5)
- Dorso-ventral axis formation (4)
- Glycerophospholipid metabolism (4)
- Inositol phosphate metabolism (3)
- Phosphatidylinositol signaling system (3)
- Vibrio cholerae infection (3)
- Arginine and proline metabolism (2)
- Alanine (1)
- Butanoate metabolism (1)
- Chondroitin sulfate biosynthesis (1)
- Glycolysis / Gluconeogenesis (1)
- Glycosphingolipid biosynthesis - lacto and neolacto series (1)
- Heparan sulfate biosynthesis (1)
- Taurine and hypotaurine metabolism (1)
- aspartate and glutamate metabolism (1)
- beta-Alanine metabolism (1)